CDSCO Registration Process, Regulatory Framework & Compliance

CDSCO Registration: Gatekeeper of India’s Healthcare

India’s healthcare sector covers pharmaceutical medicines, vaccines, biological products, medical devices, diagnostic kits, cosmetics, clinical research and several other products that directly affect human health. Unlike ordinary consumer goods, a defective medicine, unsafe implant, inaccurate diagnostic kit or improperly tested cosmetic may cause serious injury, treatment failure or even loss of life. For this reason, healthcare products cannot be freely manufactured, imported, tested or marketed without regulatory supervision. The Central Drugs Standard Control Organisation, commonly known as CDSCO, functions as India’s national regulatory authority for drugs, medical devices, cosmetics and clinical trials.

CDSCO works under the Directorate General of Health Services, Ministry of Health and Family Welfare. Its responsibilities include approval of new drugs, permission for clinical trials, regulation of imported drugs and medical devices, laying down drug standards and coordinating the activities of State Drug Control Authorities. CDSCO Registration is therefore considered the gatekeeper of India’s healthcare sector. It determines whether a regulated product or activity can legally enter, operate and continue in the Indian market.

What Is CDSCO Registration?

CDSCO Registration is a broad term used for the licences, registrations, permissions and approvals granted under India’s drug, medical device, cosmetic and clinical research laws. There is no single universal certificate known as a “CDSCO Registration Certificate” that applies to every healthcare product. The required approval depends on several factors, including the nature of the product, its intended use, risk classification, manufacturing location and whether it is manufactured in India or imported from another country.

For example, an overseas medical device manufacturer may require an import licence, while an Indian medical device manufacturer may require a manufacturing licence. A company introducing a new pharmaceutical formulation may require new drug permission, whereas an importer of foreign cosmetics may require an Import Registration Certificate. Therefore, the first and most important step in CDSCO compliance is identifying the correct regulatory category and approval route.

Why Is CDSCO Called the Gatekeeper of Indian Healthcare?

CDSCO acts as a gatekeeper because it examines whether regulated healthcare products meet the required standards before they reach patients, hospitals, laboratories, pharmacies and consumers. Its function is not limited to issuing licences. CDSCO evaluates product quality, safety, efficacy and performance. It may review manufacturing processes, technical specifications, stability studies, clinical evidence, risk-management documents and labelling information.

After approval, CDSCO may continue monitoring the product through inspections, adverse-event reporting, post-market surveillance, sample testing, complaint investigations and product recalls. This combination of pre-market examination and post-market supervision helps prevent substandard, unsafe, misbranded, adulterated or unapproved healthcare products from entering or remaining in the Indian market.

Legal Context Governing CDSCO Registration

CDSCO operates primarily under the Drugs and Cosmetics Act, 1940 and the rules framed under it. However, different categories of healthcare products are governed through separate regulatory contexts.

Drugs and Cosmetics Act, 1940

The Drugs and Cosmetics Act, 1940 is the principal legislation regulating the import, manufacture, distribution and sale of drugs and cosmetics in India. It provides the legal foundation for standards, licensing requirements, inspections, sample testing, enforcement action and penalties relating to regulated healthcare products.

Drugs Rules, 1945

The Drugs Rules, 1945 prescribe detailed requirements for the import, manufacture, sale, distribution, testing and labelling of pharmaceutical drugs. These rules also specify different application forms, licences, manufacturing conditions and quality-control requirements.

Medical Devices Rules, 2017

Medical devices and in-vitro diagnostic devices are regulated under the Medical Devices Rules, 2017. The rules establish risk-based classification, manufacturing and import-licensing procedures, quality-management requirements, clinical investigation provisions and post-market obligations.

New Drugs and Clinical Trials Rules, 2019

The New Drugs and Clinical Trials Rules, 2019 regulate new drugs, investigational new drugs, clinical trials, bioavailability and bioequivalence studies, Ethics Committees and related activities. They contain detailed provisions regarding clinical trial permission, participant protection, informed consent, serious adverse-event reporting, compensation and regulatory responsibilities.

Cosmetics Rules, 2020

The Cosmetics Rules, 2020 separately regulate the manufacture and import of cosmetics. They prescribe the process for registration of imported cosmetics, permission for new cosmetics, manufacturing licences, product standards and labelling requirements.

CDSCO and State Drug Authorities: Understanding the Difference

Healthcare regulation in India is divided between CDSCO and the State Drug Control Authorities. CDSCO generally acts as the Central Licensing Authority for new drug approvals, clinical trials, imported drugs, imported medical devices, investigational medical devices and the manufacture of certain high-risk medical devices.

State Licensing Authorities generally issue manufacturing and sale licences for several categories of pharmaceutical products and lower-risk medical devices. They also inspect manufacturing and distribution premises, collect samples and take enforcement action within their respective states. A business may therefore require approval from CDSCO, the State Licensing Authority or both. For example, a pharmaceutical company may first obtain new drug permission from CDSCO and thereafter apply to the appropriate State Licensing Authority for a commercial manufacturing licence.

CDSCO Registration for Pharmaceutical Drugs

Registration of Imported Drugs

An overseas pharmaceutical manufacturer intending to sell its products in India may be required to register its manufacturing premises and products with CDSCO. The application generally includes details of the foreign manufacturer, manufacturing facility, manufacturing licence, Good Manufacturing Practices compliance, product composition, specifications, manufacturing process, stability data, labels and regulatory status in other countries. The Indian importer or authorised agent must also possess the licences and infrastructure required to import, store and distribute pharmaceutical products.

Import Licence for Drugs

After completing the applicable registration requirements, the importer must obtain the relevant import licence before commercially importing the drug into India. Possession of an Importer Exporter Code alone does not authorise the import of pharmaceutical drugs. The importer must separately comply with the Drugs and Cosmetics Act, the Drugs Rules and CDSCO requirements.

New Drug Approval

A pharmaceutical product may be treated as a new drug where it involves a new active substance, new indication, new dosage form, new strength, new route of administration or new fixed-dose combination. The applicant may be required to submit detailed quality, non-clinical and clinical information demonstrating the safety, efficacy and quality of the proposed product. Depending on the nature of the product, CDSCO may refer the application to a Subject Expert Committee for scientific evaluation. The committee may recommend approval, rejection, additional data or further clinical studies.

New Drug Permission and Manufacturing Licence

New drug permission and a manufacturing licence are separate approvals. CDSCO may grant permission to manufacture or import the new drug for sale and distribution. However, an Indian manufacturer may still need to obtain the appropriate manufacturing licence from the State Licensing Authority before beginning commercial production.

Vaccines and Biological Products

Vaccines, recombinant products, blood products, sera, gene therapies, stem-cell products and other biological products undergo detailed regulatory evaluation. The applicant may have to submit information relating to source materials, manufacturing consistency, purity, potency, safety, clinical evidence, batch testing and pharmacovigilance. Because biological products are complex and sensitive, changes in manufacturing processes, production sites or quality specifications may also require prior regulatory approval.

CDSCO Registration for Medical Devices

Meaning of a Medical Device

A medical device may include an instrument, apparatus, implant, appliance, material, software or other article intended for diagnosis, prevention, monitoring, treatment or management of a disease, injury or medical condition. All medical devices are regulated under the Drugs and Cosmetics Act and the Medical Devices Rules, 2017.

Classification of Medical Devices

Medical devices are classified according to their risk level:

Device class	Risk level
Class A	Low risk
Class B	Low-to-moderate risk
Class C	Moderate-to-high risk
Class D	High risk

Classification depends on factors such as intended purpose, duration of use, invasiveness, whether the device is implantable and the possible consequences of device failure. Correct classification is essential because it determines the licensing authority, application form, documents, inspection requirements and government fees.

Class A Medical Devices

Class A medical devices generally present a low level of risk. Certain non-sterile and non-measuring Class A devices have been exempted from the licensing regime, subject to the applicable regulatory conditions. Other Class A devices remain subject to the prescribed licensing, quality and labelling requirements.

Class B Medical Devices

Class B medical devices carry a low-to-moderate risk. Their manufacture is generally regulated by the State Licensing Authority. A quality-management-system audit may be conducted by a registered Notified Body before or after the grant of the licence, depending on the applicable requirements.

Class C Medical Devices

Class C devices carry a moderate-to-high risk. Their manufacture is generally licensed by the Central Licensing Authority. The application normally requires detailed technical documentation, risk analysis, performance evidence, quality-system information and clinical data where applicable.

Class D Medical Devices

Class D devices are high-risk products. These may include certain implants, life-supporting devices and devices whose failure may create a serious risk to the patient. Such applications receive the highest level of regulatory examination and may require substantial technical, clinical and post-market evidence.

Manufacturing Licence for Class A and Class B Devices

An application for a manufacturing licence for eligible Class A and Class B devices is generally made in Form MD-3, while a loan-licence application is made in Form MD-4. The manufacturing licence may be issued in Form MD-5, while a loan licence may be issued in Form MD-6. The concerned State Licensing Authority generally processes these applications.

Manufacturing Licence for Class C and Class D Devices

Manufacturers of Class C and Class D medical devices generally apply to the Central Licensing Authority. An application for a manufacturing licence is made in Form MD-7 and the licence is issued in Form MD-9. A loan-licence application may be made in Form MD-8, with the licence granted in Form MD-10.

Import Licence for Medical Devices

A foreign medical device manufacturer intending to sell devices in India must generally appoint an authorised Indian agent. The authorised agent submits an application in Form MD-14 for the grant of an import licence in Form MD-15. This route applies to regulated medical devices across Classes A, B, C and D.

The application may include a Power of Attorney, Free Sale Certificate, Quality Management System certificate, Plant Master File, Device Master File, labels, instructions for use, clinical evidence and post-market surveillance information.

Investigational Medical Devices

A medical device that does not have a predicate device in India may require clinical investigation and separate permission before commercial manufacture or import. An application to conduct a clinical investigation is generally made in Form MD-22 and permission is granted in Form MD-23.

After completion of the required investigation, an application to import or manufacture a device without a predicate device may be submitted in Form MD-26, with permission granted in Form MD-27.

CDSCO Registration for In-Vitro Diagnostic Devices

Meaning of an IVD

An in-vitro diagnostic device, commonly known as an IVD, is used to examine specimens obtained from the human body. These products may include diagnostic kits, reagents, analysers, blood-grouping products, pregnancy testing kits and infectious-disease detection systems. IVDs are regulated under the Medical Devices Rules, 2017 and are classified into Classes A, B, C and D according to their risk.

Manufacture and Import of IVDs

The manufacturing route depends on the IVD’s risk class. Imported IVDs generally require an application in Form MD-14 for an import licence in Form MD-15. The applicant may need to submit analytical performance data, clinical performance evidence, stability data, quality-system documents, labels and details of the foreign manufacturer.

Clinical Performance Evaluation

A new IVD may require clinical performance evaluation to establish sensitivity, specificity, accuracy and reliability. Permission to conduct clinical performance evaluation may be sought in Form MD-24 and granted in Form MD-25. An application to import or manufacture a new IVD may be submitted in Form MD-28, with permission granted in Form MD-29.

CDSCO Registration for Imported Cosmetics

Import Registration Certificate

Cosmetics manufactured outside India generally require registration before they can be commercially imported and sold in India. An application is made online in Form COS-1 for the grant of an Import Registration Certificate in Form COS-2. The application may be submitted by the foreign manufacturer, its authorised Indian agent, an importer or an Indian subsidiary authorised by the manufacturer. The registration is linked to the foreign manufacturer, manufacturing premises, cosmetic category, product variants and pack sizes.

Documents for Cosmetic Import Registration

The application may require an authorisation from the foreign manufacturer, manufacturing licence, Free Sale Certificate, product composition, specifications, test methods, product labels and details of countries where the product is marketed. The names and addresses of the manufacturer, manufacturing site and Indian agent must remain consistent across all documents. Product names, variants, categories and pack sizes must also match the information stated in Form COS-1.

New Cosmetics

A cosmetic containing a novel ingredient that has not been recognised for cosmetic use may be treated as a new cosmetic. The applicant must generally obtain prior permission in Form COS-3 before applying for registration or import of the new cosmetic. The authority may require safety data, scientific literature, ingredient specifications and supporting evidence establishing that the cosmetic is safe for its intended use.

Clinical Trial Approval

Prior Permission from CDSCO

A clinical trial involving a new drug or investigational new drug generally requires prior permission from the Central Licensing Authority. The application normally includes the clinical trial protocol, investigator brochure, informed-consent documents, details of investigators and trial sites, safety information, proposed statistical methods and compensation arrangements. No clinical trial of a new drug should be commenced without the applicable regulatory permission or legally recognised deemed approval under the New Drugs and Clinical Trials Rules, 2019.

Ethics Committee Approval

In addition to CDSCO permission, the trial must be reviewed and approved by a registered Ethics Committee before participants are enrolled. The Ethics Committee examines the scientific and ethical aspects of the study, including participant selection, informed consent, risks, expected benefits, confidentiality and compensation arrangements.

Informed Consent

Clinical trial participants must receive understandable information regarding the purpose of the study, procedures, possible risks, expected benefits, alternative treatment options and their right to withdraw. Consent must be voluntary and recorded in the manner prescribed under the applicable rules.

Serious Adverse Events and Compensation

Serious adverse events occurring during a clinical trial must be reported within the prescribed timelines. The sponsor and investigator may also be responsible for providing medical management and compensation where the injury or death is related to the clinical trial.

Registration of Ethics Committees

An Ethics Committee reviewing clinical trials or BA/BE studies must be registered under the New Drugs and Clinical Trials Rules, 2019. The committee should include members from medical, scientific, non-scientific, legal, social and ethical backgrounds. It must function independently and maintain adequate records of its meetings and decisions.

Registration granted in Form CT-02 under the current statutory rules remains valid for five years unless suspended or cancelled. An application for renewal must be submitted within the prescribed period before expiry. The Ethics Committee must continuously review approved studies, examine protocol amendments and monitor safety information.

Registration of Clinical Research Organisations

Clinical Research Organisations perform activities such as clinical trial management, monitoring, data handling, site coordination and regulatory support for study sponsors. Following amendments to the New Drugs and Clinical Trials Rules, registration of eligible Clinical Research Organisations became part of the CDSCO regulatory context.

The CDSCO online application process for CRO registration through Form CT-07B was launched on the SUGAM portal in March 2025. A CRO is expected to maintain qualified personnel, appropriate systems, standard operating procedures, data-integrity controls, quality-assurance arrangements and adequate records.

Who Needs CDSCO Registration?

CDSCO approval or registration may be required by:

Pharmaceutical Manufacturers

Businesses manufacturing new drugs, vaccines, biological products or other centrally regulated pharmaceutical products may require CDSCO approval in addition to a State manufacturing licence.

Drug Importers

Importers of pharmaceutical drugs must obtain the applicable registration and import licence before commercial import.

Medical Device Manufacturers

Manufacturers of medical devices must obtain the applicable licence based on the device’s risk classification and regulatory route.

Medical Device Importers

Foreign medical device manufacturers and their Indian authorised agents must obtain an import licence before marketing regulated devices in India.

Cosmetic Importers

Imported cosmetics must be registered under the Cosmetics Rules, 2020 before commercial import and sale.

Clinical Trial Sponsors

Sponsors proposing to conduct regulated clinical trials must obtain the applicable CDSCO permission and Ethics Committee approval.

Clinical Research Organisations

CROs performing regulated clinical research activities may require registration with CDSCO.

Ethics Committees

Ethics Committees reviewing regulated clinical trials or BA/BE studies must obtain and maintain valid registration.

BA/BE Study Centres

Bioavailability and bioequivalence study centres must meet the prescribed registration, infrastructure and compliance requirements.

Medical Device Testing Laboratories

Laboratories testing medical devices on behalf of manufacturers may require registration in Form MD-40 after applying in Form MD-39.

Basic Eligibility Requirements

Legally Recognised Entity

The applicant should be a valid legal entity, such as a company, LLP, partnership firm, proprietorship, institution or authorised foreign manufacturer, depending on the applicable approval route.

Suitable Premises

Manufacturing, storage and testing premises should be suitable for the proposed products and activities. The facility should have adequate space, environmental controls, sanitation, safety systems and arrangements to prevent contamination and mix-ups.

Qualified Technical Personnel

Manufacturing, testing and quality-control activities must be supervised by appropriately qualified and experienced personnel. The qualifications depend on the product category and the licence being applied for.

Quality Management System

The applicant must maintain a documented quality-management system covering procurement, manufacturing, testing, storage, distribution, complaints, recalls and corrective action. Medical device manufacturers must comply with the quality-management requirements prescribed under the Medical Devices Rules.

Regulatory and Financial Capability

The applicant must demonstrate that it is capable of continuously complying with regulatory requirements, maintaining records, investigating complaints, reporting adverse events and undertaking recalls when required.

Documents Required for CDSCO Registration

The documents depend on the type of product and application. However, the following categories are commonly required.

Business Documents

The applicant may need to submit its Certificate of Incorporation, constitutional documents, PAN, GST registration, Importer Exporter Code, registered-office proof and authorised-signatory details.

Manufacturing Documents

A manufacturer may be required to submit the manufacturing licence, factory details, site layout, equipment list, production-process flow chart, technical personnel details and quality-control arrangements.

Foreign Manufacturer Documents

A foreign manufacturer may need to provide a Power of Attorney in favour of the Indian authorised agent, manufacturing licence, Free Sale Certificate, Good Manufacturing Practices certificate and regulatory approvals obtained in other countries.

Product Documents

Product-related documents may include composition, specifications, manufacturing process, testing methods, stability reports, risk analysis, safety reports, clinical evidence, labels and instructions for use.

Plant Master File

The Plant Master File describes the manufacturing facility, organisation, personnel, premises, equipment, quality systems, manufacturing operations and storage arrangements.

Device Master File

The Device Master File contains product-specific information, including the device description, intended use, classification, design, manufacturing process, risk management, verification, validation and clinical evidence.

Clinical Documents

Applications for new drugs, high-risk medical devices and investigational products may require non-clinical studies, clinical trial reports, performance data and risk-benefit analysis.

CDSCO Registration Process

Step 1: Classify the Product

The applicant must first determine whether the product is a drug, new drug, medical device, IVD, cosmetic, biological product or another regulated item. The intended purpose, ingredients, claims and mode of action should be carefully examined.

Step 2: Identify the Regulatory Authority

The applicant should determine whether the application falls under CDSCO, the State Licensing Authority or both. For medical devices, the risk class must also be confirmed.

Step 3: Appoint an Indian Authorised Agent

A foreign manufacturer generally appoints an eligible Indian authorised agent to represent it before CDSCO. The appointment should be supported by a properly executed Power of Attorney covering the relevant products and manufacturing sites.

Step 4: Create an Online Account

Several CDSCO services are available through the SUGAM portal. CDSCO also maintains a separate online system for medical device applications and links to the National Single Window System for specified services. The applicant must create the appropriate profile and select the correct regulatory service.

Step 5: Prepare the Application Dossier

The administrative and technical documents should be prepared according to the applicable rules, guidance documents and checklists. All names, addresses, product details, pack sizes and manufacturing-site information must remain consistent.

Step 6: Pay the Government Fees

The applicable government fees depend on the product, manufacturing sites, number of products, device class and nature of the application. Proof of payment must be uploaded or linked with the online application.

Step 7: Submit the Application

The prescribed application form and supporting documents are submitted through the appropriate online portal. The applicant should verify that every mandatory document is legible, valid and correctly uploaded.

Step 8: Regulatory Scrutiny

CDSCO examines the application from administrative, technical and regulatory perspectives. The authority may review product quality, manufacturing systems, safety evidence, clinical data, labels and regulatory history.

Step 9: Respond to Queries

CDSCO may raise queries or seek clarification. The applicant should provide a point-wise response supported by properly indexed documents. Incomplete or unsupported replies may result in repeated queries or rejection.

Step 10: Inspection or Audit

A manufacturing-site inspection or quality-system audit may be conducted depending on the product category and risk class. Foreign manufacturing sites may also be inspected where CDSCO considers it necessary.

Step 11: Grant of Licence or Approval

Once the authority is satisfied that the applicant meets the applicable requirements, it may issue the registration, permission or licence. The approval may contain specific conditions relating to manufacture, import, labelling, safety reporting and post-market surveillance.

Time Required for CDSCO Registration

There is no single timeline applicable to every CDSCO application. The processing period depends on the product category, risk classification, completeness of the documents, need for clinical data, requirement of inspection and number of regulatory queries. A cosmetic import registration may involve a different level of examination from a new drug, vaccine or Class D medical device application.

Businesses should therefore begin the registration process well before the proposed commercial launch or import date. A regulated product should not be commercially imported, manufactured or sold merely because an application is pending.

Validity and Retention of CDSCO Approvals

The validity of an approval depends on the product and licence category. Certain registrations and licences have a defined validity period and require renewal. Other licences remain valid unless suspended or cancelled, subject to payment of retention fees at prescribed intervals.

Medical device manufacturing and import licences generally remain valid subject to payment of the required retention fee after every five-year period. Applicants should maintain a compliance calendar for licence validity, retention fees, renewals and post-approval submissions.

Post-Registration Compliance

Obtaining CDSCO registration is not the end of regulatory responsibility. Licence holders must continuously comply with the conditions of approval.

Manufacturing and Testing Records

Manufacturers must maintain batch-manufacturing records, testing reports, equipment records, deviation reports and product-release documents.

Complaint Handling

A documented procedure should be maintained for receiving, investigating and resolving product complaints.

Complaints involving serious quality or safety concerns must be escalated without delay.

Post-Market Surveillance

Medical device and pharmaceutical businesses must monitor the safety and performance of products after they enter the market.

Post-market information may include complaints, adverse events, product failures, field-safety notices and recall data.

Adverse-Event Reporting

Serious adverse events and device incidents must be reported in accordance with the applicable regulatory timelines.

Product Recall

The licence holder should maintain a written recall procedure and adequate distribution records to trace affected batches or devices.

Change Control

Changes in the manufacturing site, product composition, manufacturing process, label, intended use or Indian authorised agent may require prior approval or endorsement.

An approved product should not be materially changed without examining the regulatory implications.

CDSCO Labelling Requirements

Product labels are an important part of regulatory compliance.

Depending on the product category, the label may need to mention:

• Product name and composition;
• Batch or lot number;
• Manufacturing and expiry dates;
• Storage conditions;
• Manufacturer’s name and address;
• Importer’s name and address;
• Manufacturing or import-licence number;
• Warnings and precautions;
• Intended use;
• Sterilisation status;
• Instructions for use; and
• Single-use or prescription-related declarations.

The claims appearing on packaging, promotional material, websites and advertisements should remain consistent with the approved intended use.

Common Reasons for Delay or Rejection

• Incorrect Product Classification: Incorrectly classifying a medical device as a cosmetic or a new drug as an ordinary drug may lead to the wrong regulatory route.
• Incomplete Technical Dossier: Missing product specifications, stability reports, clinical evidence or quality documents can result in regulatory queries.
• Mismatch in Manufacturer Details: Differences in the manufacturer’s name or address across the Power of Attorney, Free Sale Certificate, manufacturing licence and application form are common reasons for delay.
• Improper Power of Attorney: The Power of Attorney may be considered deficient where it does not clearly identify the manufacturer, authorised agent, products or manufacturing sites.
• Inconsistent Product Details: Product names, models, variants, categories and pack sizes must remain consistent across the application and supporting documents.
• Incorrect Labelling: Labels that do not contain the required declarations or make unsupported claims may be rejected.
• Failure to Respond to Queries: Failure to provide a complete response within the prescribed time may result in closure or rejection of the application.
• Incorrect Fee Payment: Payment of an incorrect fee or failure to link the payment with the application may delay processing.

Benefits of CDSCO Registration

• Legal Market Access: A valid CDSCO approval allows regulated healthcare products to be legally manufactured, imported or marketed in India.
• Patient and Consumer Safety: The approval process ensures that the product undergoes an appropriate level of technical and regulatory examination.
• Business Credibility: CDSCO approval improves confidence among hospitals, doctors, distributors, laboratories, investors and institutional buyers.
• Government and Institutional Tenders: Government hospitals and institutional buyers generally require valid regulatory approvals before purchasing healthcare products.
• Customs Clearance: A valid registration and import licence support lawful customs clearance of imported drugs, devices and cosmetics.
• Market Expansion: CDSCO approval provides the regulatory foundation for appointing distributors, supplying hospitals and expanding business operations across India.
• Reduced Enforcement Risk: Proper registration reduces the risk of import detention, product seizure, licence suspension, penalties and prosecution.

Penalties of Operating Without CDSCO Approval

Manufacturing, importing or selling a regulated product without the applicable approval can result in serious legal penalties. Authorities may detain imported consignments, seize products, suspend or cancel licences and order product recalls. The company and responsible persons may also face penalties or prosecution under the applicable law.

In addition to legal penalties, non-compliance can severely damage the reputation of the business among healthcare professionals, distributors, hospitals and consumers.

CDSCO Registration and Other Regulatory Approvals

CDSCO Registration and BIS Certification

CDSCO approval and BIS certification serve different purposes. CDSCO regulates the quality, safety, efficacy and performance of healthcare products. BIS certification confirms compliance with an applicable Indian Standard. Certain products may require both CDSCO approval and BIS certification.

CDSCO Registration and IEC

An Importer Exporter Code permits an entity to engage in international trade. It does not authorise the import of regulated healthcare products. A business may require both IEC and CDSCO approval.

CDSCO Registration and ISO Certification

ISO certification may demonstrate compliance with a quality-management standard. However, it does not replace the statutory licence or approval required from CDSCO.

CDSCO Registration and State Drug Licence

CDSCO grants central approvals for specified products and activities, while State Licensing Authorities grant various manufacturing and sale licences. Depending on the business activity, both approvals may be required.

Recent Regulatory Developments

India’s healthcare regulatory system is increasingly moving towards online filing, digital scrutiny and risk-based supervision. CRO registration applications have been made available through the SUGAM portal. CDSCO has also introduced parallel submission and processing of certain clinical trial applications by CDSCO and registered Ethics Committees.

In January 2026, the New Drugs and Clinical Trials Rules were amended to introduce a prior-intimation framework for certain BA/BE studies conducted for export purposes. CDSCO subsequently issued online procedures and FAQs for the new system. These developments show that regulated businesses must continuously monitor procedural changes even after obtaining their initial registrations.

Conclusion

CDSCO Registration plays a central role in protecting India’s healthcare market by ensuring that medicines, medical devices, diagnostic products, cosmetics, vaccines and other regulated products meet the required standards before reaching patients and consumers. The process starts with correct product classification and may involve appointment of an authorised Indian agent, preparation of technical documents, online application, payment of fees, regulatory review and inspection of the manufacturing facility. Obtaining CDSCO approval gives businesses lawful access to the Indian market, improves credibility and supports participation in hospital, institutional and government procurement.

However, approval also brings ongoing responsibilities such as quality control, proper labelling, complaint handling, safety reporting, record maintenance and post-market surveillance. Compliance Calendar LLP assists manufacturers, importers and healthcare businesses with CDSCO registration, documentation and regulatory compliance. For professional assistance, contact us at info@ccoffice.in or call 9988424211 to discuss your registration requirements and avoid delays during the approval process.

Frequently Asked Questions

Q1. Is CDSCO Registration mandatory for every healthcare product?

Ans. CDSCO approval is mandatory for products and activities covered under the Drugs and Cosmetics Act and the applicable rules. The exact requirement depends on the product’s composition, intended use and risk classification.

Q2. Does CDSCO issue one common certificate?

Ans. No. CDSCO issues different registrations, licences and permissions for different products and activities.

Q3. Can a foreign manufacturer apply directly?

Ans. A foreign manufacturer generally applies through an authorised Indian agent or Indian subsidiary, depending on the applicable rules.

Q4. Is an Indian authorised agent mandatory?

Ans. An Indian authorised agent is generally required for foreign manufacturers applying to import regulated medical devices, drugs or cosmetics.

Q5. Is CDSCO Registration required for medical devices?

Ans. Yes. Medical devices are regulated according to Classes A, B, C and D under the Medical Devices Rules, 2017.

Q6. Which form is used for importing medical devices?

Ans. An application is generally made in Form MD-14 for the grant of an import licence in Form MD-15.

Q7. Is CDSCO Registration required for imported cosmetics?

Ans. Yes. Imported cosmetics generally require an Import Registration Certificate in Form COS-2 based on an application submitted in Form COS-1.

Q8. Can one registration cover several products?

Ans. An approval may cover only the products, categories, variants, models and manufacturing sites specifically mentioned in it. Additional products may require endorsement or a fresh application.

Q9. Is an inspection mandatory?

Ans. An inspection or quality audit may be required depending on the nature of the application, product category and risk classification.

Q10. Can a product be sold while the application is pending?

Ans. A regulated product should not be commercially manufactured, imported or sold until the required approval has been granted.